These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11296070)

  • 1. Piracetam therapy does not enhance cognitive functioning in children with down syndrome.
    Lobaugh NJ; Karaskov V; Rombough V; Rovet J; Bryson S; Greenbaum R; Haslam RH; Koren G
    Arch Pediatr Adolesc Med; 2001 Apr; 155(4):442-8. PubMed ID: 11296070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled crossover study of the effects of levetiracetam on cognition, mood, and balance in healthy older adults.
    Schoenberg MR; Rum RS; Osborn KE; Werz MA
    Epilepsia; 2017 Sep; 58(9):1566-1574. PubMed ID: 28731266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of piracetam on cognitive performance in a mouse model of Down's syndrome.
    Moran TH; Capone GT; Knipp S; Davisson MT; Reeves RH; Gearhart JD
    Physiol Behav; 2002 Nov; 77(2-3):403-9. PubMed ID: 12419416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piracetam therapy for Down syndrome: a rush to judgment?
    Black SL
    Arch Pediatr Adolesc Med; 2001 Oct; 155(10):1176; author reply 1177-8. PubMed ID: 11576019
    [No Abstract]   [Full Text] [Related]  

  • 5. Concern about Piracetam treatment for children with Down syndrome.
    Holmes LB
    Pediatrics; 1999 May; 103(5 Pt 1):1078-9. PubMed ID: 10357649
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction between psychological and pharmacological treatment in cognitive impairment.
    Deberdt W
    Life Sci; 1994; 55(25-26):2057-66. PubMed ID: 7997065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of the effect of therapeutic dietary supplements and drugs on cognitive function in subjects with Down syndrome.
    Salman M
    Eur J Paediatr Neurol; 2002; 6(4):213-9. PubMed ID: 12374588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebroprotective effect of piracetam in patients undergoing open heart surgery.
    Holinski S; Claus B; Alaaraj N; Dohmen PM; Neumann K; Uebelhack R; Konertz W
    Ann Thorac Cardiovasc Surg; 2011; 17(2):137-42. PubMed ID: 21597409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piracetam for dementia or cognitive impairment.
    Flicker L; Grimley Evans G
    Cochrane Database Syst Rev; 2001; (2):CD001011. PubMed ID: 11405971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive effects of piracetam in adults with memory impairment: A systematic review and meta-analysis.
    Gouhie FA; Barbosa KO; Cruz ABR; Wellichan MM; Zampolli TM
    Clin Neurol Neurosurg; 2024 Aug; 243():108358. PubMed ID: 38878641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
    Tariska P; Paksy A
    Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The consequences of closed traumatic brain injury and piracetam efficacy in their treatment in adolescents].
    Zavadenko NN; Guzilova LS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):43-8. PubMed ID: 18427539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of piracetam on involuntary movements in Huntington's disease. A double-blind, placebo-controlled study].
    Mateo D; Giménez-Roldán S
    Neurologia; 1996 Jan; 11(1):16-9. PubMed ID: 8714171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piracetam study: poorly designed and misinterpreted.
    Croom J
    Arch Pediatr Adolesc Med; 2001 Oct; 155(10):1176-8. PubMed ID: 11576020
    [No Abstract]   [Full Text] [Related]  

  • 15. Piracetam for dementia or cognitive impairment.
    Flicker L; Grimley Evans J
    Cochrane Database Syst Rev; 2000; (2):CD001011. PubMed ID: 10796585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of piracetam on recovery and rehabilitation after stroke: a double-blind, placebo-controlled study.
    Enderby P; Broeckx J; Hospers W; Schildermans F; Deberdt W
    Clin Neuropharmacol; 1994 Aug; 17(4):320-31. PubMed ID: 9316679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piracetam: a novel therapy for autism?
    Paczynski M
    J Autism Dev Disord; 1997 Oct; 27(5):628-30. PubMed ID: 9403377
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial.
    de la Torre R; de Sola S; Hernandez G; Farré M; Pujol J; Rodriguez J; Espadaler JM; Langohr K; Cuenca-Royo A; Principe A; Xicota L; Janel N; Catuara-Solarz S; Sanchez-Benavides G; Bléhaut H; Dueñas-Espín I; Del Hoyo L; Benejam B; Blanco-Hinojo L; Videla S; Fitó M; Delabar JM; Dierssen M;
    Lancet Neurol; 2016 Jul; 15(8):801-810. PubMed ID: 27302362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piracetam--an old drug with novel properties?
    Winnicka K; Tomasiak M; Bielawska A
    Acta Pol Pharm; 2005; 62(5):405-9. PubMed ID: 16459490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piracetam as an adjuvant to language therapy for aphasia: a randomized double-blind placebo-controlled pilot study.
    Huber W; Willmes K; Poeck K; Van Vleymen B; Deberdt W
    Arch Phys Med Rehabil; 1997 Mar; 78(3):245-50. PubMed ID: 9084344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.